The U.S. Meals and Drug Administration (FDA) has accepted PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagnostic to assist establish sufferers with epithelial...
Minimal residual illness, or MRD, testing might have the potential to supply peace of thoughts to survivors of breast most cancers, as a survivor and...
Amongst sufferers with gastric or gastroesophageal junction (GEJ) adenocarcinoma, these with a baseline ECOG efficiency standing of 1 skilled worsened patient-reported outcomes...
The U.S. Meals and Drug Administration (FDA) has granted orphan drug designation to CK0804, an investigational regulatory T cell remedy developed by...
Final yr noticed a variety of therapy developments and information for sufferers with gastrointestinal cancers, together with gastrointestinal stromal tumors (GISTs), gallbladder...
